Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Red Cell Distribution Width to Predict New-onset Atrial Fibrillation in Critically Ill Sepsis Patients

NCT03523676 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT03523676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03523676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Red Cell Distribution Width to Predict New-onset Atrial Fibrillation in Critically Ill Sepsis Patients
Lead sponsor
Ain Shams University
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
March 10, 2018
Enrollment
70 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation new onset